2-Chloro-6-methyl-3-nitropyridine → HCID 86627355, compound

HRID 1896042Notes

Reaction equation

HRID 1896042 reaction equation
CC1N=C(C#CC(C2CCNCC2)O)C=CC=1.[CH3:18][C:19]1[CH:24]=[CH:23][CH:22]=[C:21]([C:25]#[C:26]/[CH:27]=[C:28]2\[CH2:29][NH:30][CH2:31][CH2:32][CH2:33]\2)[N:20]=1.Cl[C:35]1[C:40]([N+:41]([O-:43])=[O:42])=[CH:39][CH:38]=[C:37]([CH3:44])[N:36]=1>>[CH3:44][C:37]1[N:36]=[C:35]([N:30]2[CH2:31][CH2:32][CH2:33]/[C:28](=[CH:27]\[C:26]#[C:25][C:21]3[CH:22]=[CH:23][CH:24]=[C:19]([CH3:18])[N:20]=3)/[CH2:29]2)[C:40]([N+:41]([O-:43])=[O:42])=[CH:39][CH:38]=1

Participants

4

Procedure

The title compound was prepared as described for the compound of Example 237 but starting from Compound 310c or 311c instead of compound 237a and using 2-chloro-6-methyl-3-nitropyridine instead of 2-bromo-3-nitropyridine. After the work-up, the residue was purified by automated flash liquid chromatography (SP1™-Biotage) eluting with PE-EtOAc gradient from PE-EtOAc 7:3 to 6:4 affording the title products. Example 310:18%. Example 310: 11%

Workup

  1. customAfter the work-up, the residue was purified by automated flash liquid chromatography (SP1™-Biotage)
  2. washeluting with PE-EtOAc gradient from PE-EtOAc 7:3 to 6:4 affording the title products

Sources & evidence

ORD record
ord-a4d76025baad4d81b38041b82370c62d
Source dataset
uspto-grants-2013_08
Patent number
US08518916B2

Reaction notes

Loading…